Nuclear Pharmacy Practice
Conference (Sunday Only) – Pharmacists

Nuclear Pharmacy Practice <br>Conference (Sunday Only) – Pharmacists

Nuclear Pharmacy Practice
Conference (Sunday Only) – Pharmacists

Nuclear Pharmacy Practice Conference (Sunday Only) - Pharmacists

 

Sunday, October 8, 2023

Review of the Principles Related to Scintillation Detection of Radioactive Materials

8:00am-9:30am 

Kara Weatherman, PharmD, FAPhA, BCNP, Clinical Professor & Associate Department Head - Department of Pharmacy Practice, Director – Nuclear Pharmacy Programs, Purdue University

Upon completion of this activity, pharmacists will be able to: Review basic principles of setting up and operating a scintillation detector; Discuss the differences between single and multi-channel detectors; Describe the concept of efficiency and how this relates to accurate determination of radioactivity.

UAN: 0675-0000-23-016-L04-P

 

F-18 Flurpiridaz Assessment of Myocardial Perfusion-Specific Procedures

9:30am-11:00am 

Wendy Galbraith, PharmD, FAPhA, BCNP, Clinical Associate Professor, University of Oklahoma, Dept. of Pharmaceutical Sciences, College of Pharmacy, Nuclear Pharmacy & Research Imaging Facility

Upon completion of this activity, pharmacists will be able to: Recall the properties of PET and SPECT MPI tracers; Describe the PET imaging technology used for myocardial imaging; Identify clinical applications for F-18 flurpiridaz.

UAN: 0675-0000-23-021-L01-P

 

Nuclear Pharmacy: Department Questions when 795, 797, and 825 are Official – PART  2

11:15am-12:45pm 

Jessica Comstock, PharmD, BCNP, Vice President Pharmacy Quality and Regulatory, PharmaLogic Holdings

Upon completion of this activity, pharmacists will be able to: Describe the changes taking place with the implementation of USP 825, 797, and 795; Identify the additional USP chapters that are applicable to nuclear pharmacy; Discuss how internal procedures and parameters are determined and why they matter.

UAN: 0675-0000-23-022-L07-P

 

Pharmacist’s Potential Role in Radiopharmaceutical Therapy (RPT)            

12:45pm-2:15pm

Reiko Oyama, MS, RPH, BCNP, Washington University, Director, Nuclear Pharmacy

 Upon completion of this activity, pharmacists will be able to: Describe logistical, technical, and radiation safety considerations for implementing a radiopharmaceutical therapy program; List major operating procedures for the RPT example Lu-177-PSMA; Develop your own plan for implementing a radiopharmaceutical therapy program.

UAN: 0675-0000-23-023-L04-P

 

No Comments

Comments are closed.